L
Lars Bossen
Researcher at Aarhus University Hospital
Publications - 15
Citations - 237
Lars Bossen is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Cirrhosis & Medicine. The author has an hindex of 7, co-authored 10 publications receiving 169 citations. Previous affiliations of Lars Bossen include University of Milan.
Papers
More filters
Journal ArticleDOI
Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients
TL;DR: In this paper, the safety of nonselective β-blockers (NSBBs) in advanced cirrhosis has been questioned, and a large and detailed data set on worldwide non-protocol use of NSBBs in patients with ascites is presented.
Journal ArticleDOI
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers.
Lars Bossen,Lars Bossen,Alessio Gerussi,Alessio Gerussi,Vasiliki Lygoura,Vasiliki Lygoura,George F. Mells,Marco Carbone,Marco Carbone,Pietro Invernizzi +9 more
TL;DR: The clinical features and investigations that already enable us to individualize the care of PBC patients and that might support the development of precision medicine (PM) in AILDs are reviewed.
Journal ArticleDOI
Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study.
TL;DR: Using data from Danish nationwide healthcare registries to investigate the incidence and prognosis of hepatocellular adenoma, a benign liver tumour that may transform to liver cancer.
Journal ArticleDOI
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis.
Lars Bossen,Lars Bossen,Paola Rebora,Francesca Bernuzzi,Peter Uhd Jepsen,Alessio Gerussi,Pietro Andreone,Andrea Galli,B. Terziroli,Domenico Alvaro,Giancarlo Labbadia,Chiara Aloise,Leonardo Baiocchi,Edoardo G. Giannini,Ludovico Abenavoli,Pierluigi Toniutto,Fabio Marra,Marco Marzioni,Grazia Anna Niro,Annarosa Floreani,Holger Jon Møller,Maria Grazia Valsecchi,Marco Carbone,Henning Grønbæk,Pietro Invernizzi +24 more
TL;DR: In primary biliary cholangitis (PBC), macrophages are involved in liver inflammation and fibrosis and the macrophage activation markers, soluble (s)CD163 and mannose receptor (sMR) are associated with liver disease severity and prognosis in other chronic liver diseases.
Journal ArticleDOI
Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites.
TL;DR: Many patients with cirrhosis use proton pump inhibitors, and their effects on the risk and prognosis of infections in patients with Cirrhosis and ascites are studied.